KPC-2 carbapenemase-producingklebsiella pneumoniaeisolates from patients with cystic fibrosis

dc.creatorLeão, Robson S.
dc.creatorPereira, Rosana H. V.
dc.creatorFolescu, Tânia W.
dc.creatorAlbano, Rodolpho Mattos
dc.creatorSantos, Erica A.
dc.creatorC. Junior, Luiz G.
dc.creatorMarques, Elizabeth A.
dc.date2013-07-16T14:00:13Z
dc.date2013-07-16T14:00:13Z
dc.date2011
dc.date.accessioned2023-09-26T21:45:06Z
dc.date.available2023-09-26T21:45:06Z
dc.identifierLEÃO, Robson S. et al. KPC-2 carbapenemase-producingklebsiella pneumoniaeisolates from patients with cystic fibrosis. J. cyst. fibros., Amsterdam, v. 10, n. 2, p. 140-142, mar. 2011.
dc.identifier1569-1993
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/6695
dc.identifier10.1016/j.jcf.2010.12.003
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8873468
dc.descriptionAssistência Técnica da PDTIS-Fiocruz
dc.descriptionCNPq, FAPERJ
dc.descriptionBacteria producing Klebsiella pneumoniae carbapenemases (KPCs) are rapidly emerging as a cause of multidrug-resistant infections worldwide. KPCs enzyme are plasmid-borne and can accumulate and transfer resistance determinants to other classes of antibiotics.We report two cases of KPC-2 carbapenemase-producing Klebsiella pneumoniae isolates from Cystic Fibrosis patients.
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.relationLipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010;23:299–323.
dc.relationCai J, Zhou CHW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008;52:2014–8.
dc.relationLeavitt A, Chmelnitsky I, Ofek I, Carmeli Y, Navon-Venezia S. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resitance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain. J Antimicrob Chemother 2010;5:243–8.
dc.relationMaltezou H, Giakkoupi P, Maragos A, Bolikas M, Raftopoulos V, Papahatzaki H, et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniaein a hospital in Crete (Greece). J Infect 2009;8:213–9.
dc.relationNordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228–36.
dc.relationLeão RS, Carvalho-Assef APD´A, Correal JCD, Silva RV, Goldemberg DC, Asensi MD, et al. KPC-2 producing Klebsiella pneumoniae and Escherichia coli co-infection in a catheter related infection. Clin Microbiol Infect 2010 [Epub ahead of print].
dc.relationMonteiro J, Santos AF, Asensi MD, Peirano G, Gales AC. First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009;53:333–4.
dc.relationPavez M, Mamizuka EM, Lincopan N. Early dissemination of KPC-2- producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009;53:2702.
dc.relationPavez M, Mamizuka EM, Lincopan N. Early dissemination of KPC-2- producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009;53:2702.
dc.relationPournaras S, Protonotariou E, Voulgari E, Kristo I, Dimitroulia E, Vitti D, et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009;64:348–52.
dc.relationKontopoulou K, Protonotariou E, Vasilakos K, Kriti M, Koteli A, Antoniadou E, et al. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. Hosp Infect 2010;76: 70–3.
dc.relationCLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Information Supplement (June 2010 Update). CLSI. M100-S20- U. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
dc.relationAnderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:2723–5.
dc.relationOtto TD, Vasconcellos EA, Gomes LHF, Moreira AS, Degrave WM, Mendonça-Lima L, et al. ChromaPipe: a pipeline for analysis, quality control and management for a DNA sequencing facility. Genet Mol Res 2008;7:861–71.
dc.relationOtto TD, Vasconcellos EA, Gomes LHF, Moreira AS, Degrave WM, Mendonça-Lima L, et al. ChromaPipe: a pipeline for analysis, quality control and management for a DNA sequencing facility. Genet Mol Res 2008;7:861–71.
dc.relationNaas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann V. Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene. Antimicrob Agents Chemother 2008;52:1257–63.
dc.relationAkpaka PE, Swanston WH, Ihemere HN, Correa A, Torres JA, Tafur JD, et al. Emergence of KPC producing Pseudomonas aeruginosa in Trinidad and Tobago. J Clin Microbiol 2009;47:2670–1.
dc.relationPoirel L, Nordmann P, Lagrutta E, Cleary T, Munoz-Price LS. Emergence of KPC-producing Pseudomonas aeruginosa in the United States. Antimicrob Agents Chemother 2010;54:3072.
dc.relationWolter DJ, Khalaf NI, Robledo E, Vázquez GJ, Santé MI, Aquino EE, et al. Surveillance of carbapenem resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 b-lactamases. Antimicrob Agents Chemother 2009;53: 1660–4.
dc.relationCheng K, Smyth RL, Govan JRW, Doherty C, Winstanley C, Denning N, et al. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996;348:639–42.
dc.rightsrestricted access
dc.subjectCystic Fibrosis
dc.subjectKPC
dc.subjectCarbapenemases
dc.subjectKlebsiella Pneumoniae
dc.subjectInfecções por Klebsiella - microbiologia
dc.subjectKlebsiella pneumoniae - enzimologia
dc.subjectbeta-Lactamases - metabolismo
dc.subjectFibrose Cística - microbiologia
dc.subjectProteínas de Bactérias - metabolismo
dc.titleKPC-2 carbapenemase-producingklebsiella pneumoniaeisolates from patients with cystic fibrosis
dc.typeArticle


Este ítem pertenece a la siguiente institución